[EFFECT] Alpha Tau Medical Ltd. Warrant SEC Filing

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

EFFECT

07/03/2025 - 12:15 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	July 2, 2025 4:00 P.M.

Form:

F-3

CIK:	0001871321
Company Name:	Alpha Tau Medical Ltd.
File Number:	333-288240

Source: View Original Filing on SEC EDGAR

Alpha Tau Medical Ltd

NASDAQ:DRTSW

DRTSW Rankings

N/A Ranked by Market Cap

N/A Ranked by Dividends

DRTSW Latest News

Jan 6, 2026

Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study

Jan 5, 2026

Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)

Dec 18, 2025

Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference

Dec 9, 2025

Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University

Dec 4, 2025

Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium

DRTSW Latest SEC Filings

Sep 2, 2025

[6-K] Alpha Tau Medical Ltd. Warrant Current Report (Foreign Issuer)

Aug 27, 2025

[6-K] Alpha Tau Medical Ltd. Warrant Current Report (Foreign Issuer)

Aug 11, 2025

[6-K] Alpha Tau Medical Ltd. Warrant Current Report (Foreign Issuer)

Jul 24, 2025

[SCHEDULE 13G] Alpha Tau Medical Ltd. Warrant SEC Filing

Jun 23, 2025

[F-3] Alpha Tau Medical Ltd. Warrant Foreign Issuer Shelf Registration

DRTSW Stock Data

Float 23.41M

Industry Biotechnology

Sector Healthcare

Website Link

Country Israel

City Jerusalem